Therefore, the intricate relationship between IDO1 levels and clinical outcomes can be attributed to various factors such as age, sex, tumor type [6], follow-up time, study quality, IDO1/CD8 ratio [5], and IDO1 expression site [29]. The gene discussed is IDO1; the disease is neoplasm.